Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 9.08M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -6.4M | Forward P/E | -3.61 | EPS next Y | - | 50D Avg Chg | 3.00% |
| Sales | - | PEG | - | EPS past 5Y | -25.46% | 200D Avg Chg | 6.00% |
| Dividend | N/A | Price/Book | 1.42 | EPS next 5Y | - | 52W High Chg | -34.00% |
| Recommedations | 2.00 | Quick Ratio | 1.37 | Shares Outstanding | 4.47M | 52W Low Chg | 68.00% |
| Insider Own | 21.67% | ROA | -90.17% | Shares Float | 3.26M | Beta | 0.28 |
| Inst Own | 8.95% | ROE | -206.36% | Shares Shorted/Prior | 376.93K/14.33K | Price | 2.10 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 3,890 | Target Price | - |
| Oper. Margin | - | Earnings Date | Nov 12 | Volume | 1,867 | Change | 5.88% |
About Protagenic Therapeutics, Inc.
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.
Protagenic Therapeutics, Inc. News
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Arrow Alexander K. | Chief Financial Offi.. Chief Financial Officer | Oct 12 | Buy | 0.81 | 8,000 | 6,480 | 45,815 | 10/13/23 |
| Arrow Alexander K. | Chief Financial Offi.. Chief Financial Officer | May 17 | Buy | 0.72 | 31,000 | 22,320 | 151,260 | 05/18/22 |